Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations

Majumder, 1988, c-kit protein, a transmembrane kinase: Identification in tissues and characterization, Mol Cell Biol, 8, 4896, 10.1128/MCB.8.11.4896 Blume-Jensen, 1991, Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis, EMBO J, 10, 4121, 10.1002/j.1460-2075.1991.tb04989.x Fleischman, 1993, From white spots to stem cells: The role of the KIT receptor in mammalian development, Trends Genet, 9, 285, 10.1016/0168-9525(93)90015-A Blechman, 1993, Structure-function analyses of the KIT receptor for the Steel factor, Stem Cells, 11, 12 Zhang, 2000, Crystal structure of human stem cell factor: Implication for stem cell factor receptor dimerization and activation, Proc Natl Acad Sci U S A, 97, 7732, 10.1073/pnas.97.14.7732 Russell, 1979, Hereditary anemias of the mouse: A review for geneticists, Adv Genet, 20, 357, 10.1016/S0065-2660(08)60549-0 Kitamura, 1979, Decreased production of mast cells in S1/S1d anemic mice, Blood, 53, 492, 10.1182/blood.V53.3.492.492 Huizinga, 1995, W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity, Nature, 373, 347, 10.1038/373347a0 Isozaki, 1995, Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit–expressing cells in Ws/Ws mutant rats, Gastroenterology, 109, 456, 10.1016/0016-5085(95)90333-X Kluppel, 1998, Developmental origin and KIT-dependent development of the interstitial cells of Cajal in the mammalian small intestine, Dev Dyn, 211, 60, 10.1002/(SICI)1097-0177(199801)211:1<60::AID-AJA6>3.0.CO;2-5 Torihashi, 1999, Blockade of KIT signaling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype, Gastroenterology, 117, 140, 10.1016/S0016-5085(99)70560-3 Nakama, 1998, Disturbed pyloric motility in Ws/Ws mutant rats due to deficiency of c-kit–expressing interstitial cells of Cajal, Pathol Int, 48, 843, 10.1111/j.1440-1827.1998.tb03850.x Hirota, 1998, Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors, Science, 279, 577, 10.1126/science.279.5350.577 Nakahara, 1998, A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors, Gastroenterology, 115, 1090, 10.1016/S0016-5085(98)70079-4 Rubin, 2001, KIT activation is a ubiquitous feature of gastrointestinal stromal tumors, Cancer Res, 61, 8118 Nishida, 1998, Familial gastrointestinal stromal tumours with germline mutation of the KIT gene, Nat Genet, 19, 323, 10.1038/1209 Isozaki, 2000, Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors, Am J Pathol, 157, 1581, 10.1016/S0002-9440(10)64795-5 Hirota, 2000, Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene, Am J Surg Pathol, 24, 326, 10.1097/00000478-200002000-00045 Maeyama, 2001, Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene, Gastroenterology, 120, 210, 10.1053/gast.2001.20880 Beghini, 2001, Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa, Cancer, 92, 657, 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D Furitsu, 1993, Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product, J Clin Invest, 92, 1736, 10.1172/JCI116761 Tsujimura, 1994, Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation, Blood, 83, 2619, 10.1182/blood.V83.9.2619.2619 Tsujimura, 1995, Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3, Int Arch Allergy Immunol, 106, 377, 10.1159/000236870 Tsujimura, 1996, Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain, Blood, 87, 273, 10.1182/blood.V87.1.273.273 Nakata, 1995, c-kit point mutation of extracellular domain in patients with myeloproliferative disorders, Br J Haematol, 91, 661, 10.1111/j.1365-2141.1995.tb05364.x Tian, 1999, Activating c-kit gene mutations in human germ cell tumors, Am J Pathol, 154, 1643, 10.1016/S0002-9440(10)65419-3 Longley, 1999, Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis, Proc Natl Acad Sci U S A, 96, 1609, 10.1073/pnas.96.4.1609 Ernst, 1998, KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors, Lab Invest, 78, 1633 Moskaluk, 1999, Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors, Oncogene, 18, 1897, 10.1038/sj.onc.1202496 Lasota, 1999, Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas, Am J Pathol, 154, 53, 10.1016/S0002-9440(10)65250-9 Taniguchi, 1999, Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors, Cancer Res, 59, 4297 Lux, 2000, KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors, Am J Pathol, 156, 791, 10.1016/S0002-9440(10)64946-2 Ma, 1999, Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region, J Biol Chem, 274, 13399, 10.1074/jbc.274.19.13399 Longley, 2001, Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy, Leuk Res, 25, 571, 10.1016/S0145-2126(01)00028-5 Ma, 2002, The c-kit mutation causing human mastocytosis is resistant to STI-571 and other KIT kinase inhibitors: Kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations, Blood, 99, 1741, 10.1182/blood.V99.5.1741 Longley, 1996, Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm, Nat Genet, 12, 312, 10.1038/ng0396-312 Ma, 2000, Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells, J Invest Dermatol, 114, 392, 10.1046/j.1523-1747.2000.00888.x Wybenga-Groot, 2001, Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region, Cell, 106, 745, 10.1016/S0092-8674(01)00496-2 Ma, 1999, Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms, J Invest Dermatol, 112, 165, 10.1046/j.1523-1747.1999.00488.x Lasota, 2000, Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors: A study of 200 cases, Am J Pathol, 157, 1091, 10.1016/S0002-9440(10)64623-8 Hirota, 2001, Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours, J Pathol, 193, 505, 10.1002/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E Kimura, 1997, c-kit point mutation in patients with myeloproliferative disorders, Leuk Lymphoma, 25, 281, 10.3109/10428199709114167 Gari, 1999, c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia, Br J Haematol, 105, 894, 10.1046/j.1365-2141.1999.01449.x Gorre, 2001, Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification, Science, 293, 876, 10.1126/science.1062538 Linnekin, 1999, Early signaling pathways activated by c-Kit in hematopoietic cells, Int J Biochem Cell Biol, 31, 1053, 10.1016/S1357-2725(99)00078-3 Taylor, 2000, Kit signal transduction, Hematol Oncol Clin North Am, 14, 517, 10.1016/S0889-8588(05)70294-X Piao, 1996, Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1, Proc Natl Acad Sci U S A, 93, 14665, 10.1073/pnas.93.25.14665 Chian, 2001, Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant, Blood, 98, 1365, 10.1182/blood.V98.5.1365 Deberry, 1997, Stat1 associates with c-kit and is activated in response to stem cell factor, Biochem J, 327, 73, 10.1042/bj3270073 Shen, 2001, Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1, Proc Natl Acad Sci U S A, 98, 1543, 10.1073/pnas.98.4.1543 Lopez-Ilasaca, 1997, Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF, Biochem Biophys Res Commun, 232, 273, 10.1006/bbrc.1997.6289 Atfi, 1999, The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway, Oncogene, 18, 3878, 10.1038/sj.onc.1202734 Vosseller, 1997, c-kit receptor signaling through its phosphatidylinositide-3'-kinase–binding site and protein kinase C: Role in mast cell enhancement of degranulation, adhesion, and membrane ruffling, Mol Biol Cell, 8, 909, 10.1091/mbc.8.5.909 Jeffers, 1999, Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild-type signaling, Oncogene, 18, 5120, 10.1038/sj.onc.1202902 Colucci, 2000, The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells, Blood, 95, 984, 10.1182/blood.V95.3.984.003k40_984_991 Voss, 2000, The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways, Oncogene, 19, 1684, 10.1038/sj.onc.1203467 Kapur, 2001, A novel mechanism of cooperation between c-Kit and erythropoietin peceptor. Stem cell factor induces the expression of STAT5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin, J Biol Chem, 276, 1099, 10.1074/jbc.M007442200 Paulson, 1996, Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1, Nat Genet, 13, 309, 10.1038/ng0796-309 Kozlowski, 1998, SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain, Mol Cell Biol, 18, 2089, 10.1128/MCB.18.4.2089 Crosier, 1993, Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia, Blood, 82, 1151, 10.1182/blood.V82.4.1151.1151 Caruana, 1999, Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts, Oncogene, 18, 5573, 10.1038/sj.onc.1202939 Ashman, 1999, The biology of stem cell factor and its receptor C-kit, Int J Biochem Cell Biol, 31, 1037, 10.1016/S1357-2725(99)00076-X Boghosian, 1989, Three possible cytogenetic subgroups of leiomyosarcoma, Cancer Genet Cytogenet, 43, 39, 10.1016/0165-4608(89)90125-8 Bardi, 1992, Recurrent chromosome aberrations in abdominal smooth muscle tumors, Cancer Genet Cytogenet, 62, 43, 10.1016/0165-4608(92)90036-8 Sreekantaiah, 1993, Chromosomal abnormalities in leiomyosarcomas, Am J Pathol, 142, 293 Saunders, 1996, Two cases of low-grade gastric leiomyosarcoma with monosomy 14 as the only change, Cancer Genet Cytogenet, 90, 184, 10.1016/S0165-4608(96)00098-2 Mark, 1976, G-band analyses of a human intestinal leiomyosarcoma, Acta Pathol Microbiol Scand [A], 84, 538 el Rifai, 2000, DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance, Cancer Res, 60, 3899